
❄Lyophilized powder (not reconstituted)
Size:
Discount per Quantity
| Quantity | Discount | Price per Unit |
|---|---|---|
| 5 - 10 | 10% | €40.49 |
| 11 - 20 | 15% | €38.24 |
| 21+ | 20% | €35.99 |
Rigorous third-party testing
Every batch of our research chemicals and peptides undergoes independent third-party laboratory testing for purity and identity.
Total: €44.99
Semax is a synthetic heptapeptide nootropic derived from a fragment of adrenocorticotropic hormone (ACTH 4-10) with the addition of Pro-Gly-Pro for enhanced stability and bioavailability. Developed at the Institute of Molecular Genetics, Russian Academy of Sciences, Semax has been approved in Russia and Ukraine as a prescription medication for stroke recovery, cognitive disorders, and peptic ulcers. Its primary mechanism involves significant upregulation of BDNF (Brain-Derived Neurotrophic Factor) – a key protein for neuronal survival, growth, and synaptic plasticity. Research published in Neuroscience Letters demonstrates that Semax increases BDNF mRNA expression by up to 6-fold, enhancing cognitive function, memory, and neuroprotection.
Semax (ACTH 4-7 PGP) is one of the most clinically validated nootropic peptides, with decades of research in Russia and growing international recognition:
Semax stands as one of the few nootropic peptides with both extensive preclinical evidence and clinical application history, demonstrating a broad neuroprotective and cognitive-enhancing profile.
This product is not a drug or food and should be handled by qualified professionals in laboratory conditions. All product information is provided for educational purposes only.